Petteri T. Arstila

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.

K. Partanen, A. Hemminki, V. Cerullo, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.

A. Ristimäki, A. Hemminki, K. Guse, 2010, Cancer research.

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

S. Mustjoki, K. Porkka, A. Kreutzman, 2011, PloS one.

The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions.

A. Vaheri, Outi K. Laine, S. Mäkelä, 2013, Antiviral research.